PRV-UN TOR Week ended 07 Aug 2026

Weekly Investor Report

Pro Real Estate Investment Trust · Real Estate · Reit - Industrial

Open interactive chart View report data
Latest close 6.98 CAD
-1.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 5.9% above the Trend Line and sits at 80.9% of its 52-week range. The latest completed week returned -1.7%, after a -1.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100.

Setup score 65 out of 100
Latest Close 6.98 CAD 7 Aug 2026
1W Return -1.7% latest completed week
4W Return -1.4% short-term follow-through
12W Return 6.0% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 61-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 4 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.7% Latest completed week; four-week move -1.4%. Indicator stack 100/70 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 57.95% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 54/100 23 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 5.9% above the Trend Line and sits at 80.9% of its 52-week range. The latest completed week returned -1.7%, after a -1.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9312-week average 0.84

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.93Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.4% over four weeks, 6.0% over 12 weeks, and 28.3% over one year. The current trend has remained active for 61 consecutive weeks.

Performance by holding period

1W-1.7%
4W-1.4%
12W6.0%
26W10.6%
52W28.3%
Active trend streak61 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.13Latest activity-pressure read.
Pressure change-6.2%Four-week change in activity pressure.
Leadership-0.72Latest relative-leadership reading.
RS change-118.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength29/100Blend of value, momentum, and quality. Underlying universe rank 72; rank 1 is best.
Value36/100Relative valuation strength. Underlying universe rank 65; rank 1 is best.
Quality24/100Profitability and accounting quality. Underlying universe rank 77; rank 1 is best.
Momentum64/100Medium-term price momentum. Underlying universe rank 37; rank 1 is best.
Growth35/100Revenue and earnings growth. Underlying universe rank 66; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
13.7x
Price divided by trailing earnings.
Price / sales
5.6x
Market value relative to trailing revenue.
EV / EBITDA
16.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
61.4%
Gross profit retained from each unit of revenue.
Operating margin
51.8%
Operating profit retained from revenue.
Free-cash-flow margin
32.9%
Free cash flow generated from revenue.
Return on invested capital
4.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
4.9%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
7.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
6.5%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
6.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
7.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 23 relevant articles.

5 positive · 17 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.0%Distance below the 52-week high.
13-week volatility2.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+5.2%Week of 3 Apr.
Worst week-5.5%Week of 5 Jun.
Latest week-1.7%Week of 7 Aug.

Shape of recent returns

Strong gains2
Modest gains13
Flat weeks0
Modest losses10
Sharp losses1
Recent vol2.5%13-week weekly-return volatility.
Base vol2.1%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew1.7% / -1.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape69/100

Trend, activity pressure, participation, and risk combine to a 69/100 tape read.

 Indicator analysis78/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 9/12.

Activity pressure 0.93; 4 reversal markers Next-Week ExpectancyPositive 57.95%

Next-week expectancy is positive with a 57.95% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors36/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 63; Small Cap Core rank 39 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 23 relevant articles.

RCS - Neuberger Prv Equity - Kepler Trust Intelligence: New Research Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20266.98 CAD-1.7%6.59 CAD5.10 CAD1.13-0.72401.2KOn
31 Jul 20267.10 CAD-1.1%6.57 CAD5.09 CAD1.354.25426.2KOn
24 Jul 20267.18 CAD0.1%6.54 CAD5.07 CAD1.445.04416.2KOn
17 Jul 20267.17 CAD1.3%6.51 CAD5.05 CAD1.375.29428.1KOn
10 Jul 20267.08 CAD-1.8%6.48 CAD5.03 CAD1.213.90698.4KOn
3 Jul 20267.21 CAD4.1%6.45 CAD5.01 CAD1.035.99330.3KOn
26 Jun 20266.93 CAD1.8%6.41 CAD4.99 CAD0.752.64296.3KOn
19 Jun 20266.80 CAD2.2%6.38 CAD4.97 CAD0.610.85305.2KOn
12 Jun 20266.65 CAD3.1%6.35 CAD4.96 CAD0.52-1.31474.0KOn
5 Jun 20266.46 CAD-5.5%6.32 CAD4.94 CAD0.47-2.87377.7KOn
29 May 20266.83 CAD0.8%6.30 CAD4.93 CAD0.381.71117.7KOn
22 May 20266.78 CAD2.9%6.27 CAD4.91 CAD0.251.73146.2KOn
15 May 20266.59 CAD1.8%6.24 CAD4.89 CAD0.290.84317.8KOn
8 May 20266.47 CAD-0.2%6.20 CAD4.87 CAD0.24-1.67202.0KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context